October 6, 2011
Cambridge, MA
Effective and cost-efficient legal guidance now, more than ever, is essential for the protection of innovator small molecule and biologic pharmaceutical products. During this program our panelists will discuss:
• An Overview of the Follow-On Biologics Framework
• Strategies for Successfully Litigating Hatch-Waxman and Biosimilar Cases
• Strategies for Maximizing Small Molecule and Biosimilar Patent Protection
Finnegan
55 Cambridge Parkway
Cambridge, MA 02142
European IP Blog
UPC Central Division Revokes Patent Covering Covid-19 Treatment Remdesivir
8 June 2026
Panel Discussion
May 5, 2026
London
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.